Rare disease is a major – and growing – area of clinical research and drug development. Of the FDA’s 46 novel drug approvals ...

A recent study on chronic pain management for Canadian veterans has uncovered a critical flaw in decades of research: Not a single one examined the impact of sex or gender on treatment effectiveness.

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

BHF has introduced a policy on diversity in research design, setting clearer expectations that, wherever possible, the ...

When Elise Felicione tried to design a clinical trial for a supplement, 5 things got in the way. It’s a lesson for the ...

A prospective study of first-degree relatives of patients with MS found that this high-risk population faces significantly ...

Media psychology focusing on how and why people perceive, process, and act on digital information offers key insights into ...

Creating a clear and well-defined bioanalytical methodology to quantify humoral and cellular immune responses is critical for ...

Dynamic Image Analysis directly addresses micro-flow imaging’s inherent scalability and workflow limitations. Both ...

Study shows the use of persona prompting can cause shifts in LLMs’ moral judgements, leading to unexpected and inconsistent ...

Space agency surveyed about 360 participants living in New York City, Los Angeles, and Dallas-Fort Worth.

Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...